Category: Uncategorized

FDA Moves to Real-Time Adverse Event Reporting This is a big step toward modernizing drug safety oversight by the FDA. Starting August 22, 2025, the agency will publish daily updates from the FDA Adverse Event Reporting System (FAERS), instead of quarterly releases.It makes a difference for it leads to: 1. Faster detection of safety signals… Continue reading FDA Moves to Real-Time Adverse Event Reporting

The FDA has announced FDA PreCheck— a program to boost domestic drug (API) manufacturing. The UK Government has unveiled a major regulatory reform aimed at accelerating patient access to innovative therapies by 3–6 months, positioning the UK as a more attractive environment for life sciences innovation and investment. Under a new joint pathway, the MHRA and… Continue reading The FDA has announced FDA PreCheck— a program to boost domestic drug (API) manufacturing.

UK Streamlines Regulatory Pathway to Accelerate Market Access by 3–6 Months. The FDA has announced FDA PreCheck— a program to boost domestic drug (API) manufacturing. The program includes two phases: 1.Facility Readiness Phase – Early FDA input on facility design, quality systems, and operational maturity through a Type V DMF. 2.Application Submission Phase – Enhanced support… Continue reading UK Streamlines Regulatory Pathway to Accelerate Market Access by 3–6 Months.

Innovative Licensing and Access Pathway The UK has launched a refreshed Innovative Licensing and Access Pathway (ILAP) to expedite the delivery of transformative medicines to patients in the NHS. This pathway, unique globally, allows medicine developers to collaborate with the national health system, regulators, and health technology assessment bodies from early clinical development stages. Key… Continue reading Innovative Licensing and Access Pathway

Strategic Agenda for FDA‘s rare disease, innovation hub The FDA’s Rare Disease Innovation Hub has released its Strategic Agenda, focusing on advancing regulatory science of rare disease therapies, strengthening coordination between FDA’s Medical Product Centers, and creating a centralized point of contact for external partners. #FDA #RareDisease #StrategicAgenda #Innovation #Hub

505 (b)(2) Application A 505(b)(2) application is a type of New Drug Application (NDA) in the United States of America that allows a sponsor to obtain U.S. Food and Drug Administration (FDA) approval for a drug by relying, at least in part, on data not developed by the applicant. This can include published literature, studies… Continue reading 505 (b)(2) Application

Narrow Your Focus to Prevent Overanalysis The new wordpress theme called Consulting WP has been lauded by critics for its presentation. The theme is made by Style Mix Themes, who have been key players in the theme industry for a long time. People were excited to see what they would come up with next; their… Continue reading Narrow Your Focus to Prevent Overanalysis

Stick with Your Concept but Do Your Homework The new wordpress theme called Consulting WP has been lauded by critics for its presentation. The theme is made by Style Mix Themes, who have been key players in the theme industry for a long time. People were excited to see what they would come up with… Continue reading Stick with Your Concept but Do Your Homework

Three Social Media Hacks for the Busy Entrepreneur The new wordpress theme called Consulting WP has been lauded by critics for its presentation. The theme is made by Style Mix Themes, who have been key players in the theme industry for a long time. People were excited to see what they would come up with… Continue reading Three Social Media Hacks for the Busy Entrepreneur

Harvest great ideas from your company’s best assets Many businesses, large and small, have a huge source of great ideas that can help them improve, innovate, and grow, and yet so many of these companies never think of using this amazing corporate asset. What is this highly valuable asset? Its own people. Says Morgan Fraud,… Continue reading Harvest great ideas from your company’s best assets